BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0014
+0.0001 (7.69%)
Sep 10, 2026, 1:37 PM EST
BioAdaptives Employees
BioAdaptives had 1 employees as of June 30, 2026. The number of employees did not change compared to the same quarter last year.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
$25,561
Profits / Employee
-$1,163,844
Market Cap
256.01K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | 0 | - | 1 | 0 |
| Mar 31, 2026 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Jun 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Mar 31, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Sep 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Jun 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Mar 31, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Dec 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Sep 30, 2023 | 6 | 0 | - | 3 | 3 |
| Jun 30, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Mar 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Dec 31, 2022 | 7 | 0 | - | 3 | 4 |
| Sep 30, 2022 | 6 | -1 | -14.29% | 3 | 3 |
| Jun 30, 2022 | 7 | - | - | 3 | 4 |
| Mar 31, 2022 | 7 | - | - | 3 | 4 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
BioAdaptives News
- 7 days ago - BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress - Accesswire
- 10 days ago - UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM) - Accesswire
- 4 weeks ago - BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update - Accesswire
- 4 weeks ago - BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal - Accesswire
- 5 weeks ago - BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula - Accesswire
- 6 weeks ago - BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor - Accesswire
- 6 weeks ago - BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform - Accesswire
- 7 weeks ago - BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches - GlobeNewsWire